Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Newegg Commerce Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Newegg Commerce Inc trades at $10.79 (market cap $232.74M). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 38.1× Newegg Commerce Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Newegg Commerce Inc for 14 Days on average.
| KYMR | NEGG | |
|---|---|---|
Market Cap | $8.87B | $232.74M |
Volume | 779,107 | 40,856 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $92.74 |
52-Week Low | $55.80 | $10.61 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $8.26B | $202.98M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NEGG trades at $10.61, down 6.52% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported revenue of $1.44 billion in 2025 with a net loss of $4.88 million, though recent quarters have beaten EPS estimates. Valuation ratios show a low P/S of 0.17 but a P/E of 24.52, while cash flow trends indicate reliance on financing activities. Recent news highlights partnerships with Western Digital and Hewlett Packard Enterprise to support IT infrastructure.
The outlook is mixed: improving profitability and strategic partnerships offer upside, but persistent net losses, negative operating cash flow, and insider selling pose risks. Analyst consensus is Buy with a $7.75 price target, below the current price, suggesting cautious optimism amid operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
